10.09.24
Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace.
View full description +
Subscribe
07.30.25
Tryptyr Now Available in US07.16.25
AECOS Presentation SummariesShow More